NEW YORK (GenomeWeb) – Waters reported today that its first quarter revenues rose 7 percent year over year, as the company saw solid demand among its pharma customers but a decline in sales of its mass spectrometry instruments.

Waters posted revenues of $530.7 million for the quarter compared to $498 million in Q1 2017, below the average Wall Street estimate of $535.3 million.

Currency translation increased sales growth by around 5 percent, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.